MedTrace Logo

Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients

NCT02012504 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2013-12-16

No results posted yet for this study

Summary

The primary objective is to evaluate the improvement of antidepressant monotherapy on depressive and anxiety symptom in Chinese patients who meet Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for the comorbidity of major depressive disorder (MDD) and generalized anxiety disorder (GAD)

Conditions

  • Adverse Drug Reaction
  • Anxiety Disorders and Symptoms

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Xiao Huang, MD · Fudan University

  • Jian l Ji, MD · Fudan University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-01-31
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02012504 on ClinicalTrials.gov